Literature DB >> 21188298

EFFECT OF CYCLOSPORIN ON HEPATIC REGENERATION.

Leonard Makowka1, Gregory Svanas, Carlos Esquivel, Raman Venkataramanan, Satoru Todo, Shunzaburo Iwatsuki, David Van Thiel, Thomas E Starzl.   

Abstract

Entities:  

Year:  1986        PMID： 21188298      PMCID： PMC3008819     

Source DB:  PubMed          Journal:  Surg Forum        ISSN： 0071-8041


× No keyword cloud information.
  3 in total

1.  Liquid-chromatographic determination of cyclosporin A in blood and plasma.

Authors:  R J Sawchuk; L L Cartier
Journal:  Clin Chem       Date:  1981-08       Impact factor: 8.327

2.  Thymidine kinase: an inexpensive index of liver regeneration in a large animal model.

Authors:  D Kahn; J Stadler; J Terblanche; R van Hoorn-Hickman
Journal:  Gastroenterology       Date:  1980-11       Impact factor: 22.682

3.  Ornithine decarboxylase activity and the onset of deoxyribonucleic acid synthesis in regenerating liver.

Authors:  J A McGowan; N Fausto
Journal:  Biochem J       Date:  1978-01-15       Impact factor: 3.857
  3 in total
  16 in total

1.  Inhibition of liver, kidney, and intestine regeneration by rapamycin.

Authors:  A Francavilla; T E Starzl; C Scotti; G Carrieri; A Azzarone; Q H Zeng; K A Porter; S L Schreiber
Journal:  Transplantation       Date:  1992-02       Impact factor: 4.939

2.  FK 506 as a growth control factor.

Authors:  A Francavilla; M Barone; T E Starzl; A Zeevi; C Scotti; G Carrieri; V Mazzaferro; J Prelich; S Todo; G Eiras
Journal:  Transplant Proc       Date:  1990-02       Impact factor: 1.066

3.  Studies of the hepatotrophic qualities of FK 506 and CyA.

Authors:  V Mazzaferro; C L Scotti-Foglieni; K A Porter; J Trejo Bellido; G Carrieri; S Todo; J J Fung; A Francavilla; T E Starzl
Journal:  Transplant Proc       Date:  1990-02       Impact factor: 1.066

Review 4.  The effects of FK 506, cyclosporine, and rapamycin on liver growth in vitro and in vivo.

Authors:  A Francavilla; T E Starzl; B Carr; A Azzarone; G Carrieri; Q H Zeng; K A Porter
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

5.  Protective effect of FK 506 against hepatic ischemia in rats.

Authors:  M F Sakr; G M Zetti; H Farghali; T H Hassanein; J S Gavaler; T E Starzl; D H Van Thiel
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

6.  Hepatotrophic effects of FK506 in dogs.

Authors:  T E Starzl; K A Porter; V Mazzaferro; S Todo; J Fung; A Francavilla
Journal:  Transplantation       Date:  1991-01       Impact factor: 4.939

7.  Studies on mechanisms of augmentation of liver regeneration by cyclosporine and FK 506.

Authors:  A Francavilla; T E Starzl; M Barone; Q H Zeng; K A Porter; A Zeevi; P M Markus; M R van den Brink; S Todo
Journal:  Hepatology       Date:  1991-07       Impact factor: 17.425

Review 8.  Hepatic regeneration. Effects of age, sex hormone status, prolactin, and cyclosporine.

Authors:  D H Van Thiel; R Stauber; J S Gavaler; A Francavilla
Journal:  Dig Dis Sci       Date:  1991-09       Impact factor: 3.199

9.  A fresh look at augmenter of liver regeneration in rats.

Authors:  C R Gandhi; R Kuddus; V M Subbotin; J Prelich; N Murase; A S Rao; M A Nalesnik; S C Watkins; A DeLeo; M Trucco; T E Starzl
Journal:  Hepatology       Date:  1999-05       Impact factor: 17.425

10.  Cell proliferation and oncogene expression after bile duct ligation in the rat: evidence of a specific growth effect on bile duct cells.

Authors:  L Polimeno; A Azzarone; Q H Zeng; C Panella; V Subbotin; B Carr; B Bouzahzah; A Francavilla; T E Starzl
Journal:  Hepatology       Date:  1995-04       Impact factor: 17.425
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.